K.J. Harrison & Partners Inc raised its position in Stericycle Inc. (NASDAQ:SRCL) by 243.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 11,000 shares of the company’s stock after buying an additional 7,800 shares during the period. K.J. Harrison & Partners Inc’s holdings in Stericycle were worth $1,145,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the company. Dubuque Bank & Trust Co. increased its stake in shares of Stericycle by 42.4% in the first quarter. Dubuque Bank & Trust Co. now owns 26,048 shares of the company’s stock worth $3,287,000 after buying an additional 7,754 shares during the period. Addenda Capital Inc. increased its stake in shares of Stericycle by 182.2% in the first quarter. Addenda Capital Inc. now owns 13,587 shares of the company’s stock worth $1,714,000 after buying an additional 8,773 shares during the period. Torray LLC increased its stake in shares of Stericycle by 53.6% in the first quarter. Torray LLC now owns 420,707 shares of the company’s stock worth $53,089,000 after buying an additional 146,805 shares during the period. Badgley Phelps & Bell Inc. increased its stake in shares of Stericycle by 5.6% in the first quarter. Badgley Phelps & Bell Inc. now owns 59,172 shares of the company’s stock worth $7,467,000 after buying an additional 3,144 shares during the period. Finally, Dynamic Advisors Solutions LLC increased its stake in shares of Stericycle by 1.7% in the first quarter. Dynamic Advisors Solutions LLC now owns 5,122 shares of the company’s stock worth $646,000 after buying an additional 85 shares during the period. Institutional investors own 92.80% of the company’s stock.

Stericycle Inc. (NASDAQ:SRCL) traded up 1.62% during mid-day trading on Thursday, hitting $79.26. The company had a trading volume of 1,353,883 shares. Stericycle Inc. has a 1-year low of $76.76 and a 1-year high of $151.57. The stock has a market capitalization of $6.74 billion, a PE ratio of 27.90 and a beta of 0.27. The stock has a 50 day moving average price of $84.23 and a 200-day moving average price of $102.26.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. Stericycle’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.14 EPS. On average, analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current year.

A number of brokerages recently issued reports on SRCL. Zacks Investment Research downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Monday, July 25th. Jefferies Group reiterated a “buy” rating and issued a $125.00 price objective (down previously from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Wellington Shields downgraded Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Imperial Capital downgraded Stericycle from an “in-line” rating to an “underperform” rating and lowered their price objective for the stock from $100.00 to $93.50 in a research report on Friday, July 29th. Finally, Royal Bank Of Canada restated a “sell” rating on shares of Stericycle in a research report on Thursday, May 26th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. Stericycle presently has an average rating of “Hold” and an average target price of $108.95.

In related news, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the completion of the transaction, the director now owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.